The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL

Free Radical Biology and Medicine

Volumn 93, Issue , 2016, Pages 204-216

  Camaré, Caroline ^a,b   Augé, Nathalie ^a   Pucelle, Mélanie ^a   Saint Lebes, Bertrand ^a,b   Grazide, Marie Hélène ^b   Nègre Salvayre, Anne ^a   Salvayre, Robert ^a,b  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Angiogenesis; Cell signaling signaltransduction; Ceramide; Neutral sphingomyelinase type2; Oxidized LDL; ROSandoxidativestress

Indexed keywords

3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; CERAMIDE; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; SPHINGOMYELIN PHOSPHODIESTERASE; ANILINE DERIVATIVE; BENZYLIDENE DERIVATIVE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; SMPD3 PROTEIN, HUMAN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHORIOALLANTOIC MEMBRANE ASSAY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

ANILINE COMPOUNDS; ANIMALS; APOPTOSIS; BENZYLIDENE COMPOUNDS; CERAMIDES; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; LYSOPHOSPHOLIPIDS; MICE; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REACTIVE OXYGEN SPECIES; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TRANSCRIPTIONAL ACTIVATION;

EID: 84958213093     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.02.006     Document Type: Article

References (57)

1. M.J. Mulligan-Kehoe, and M. Simons Vasa vasorum in normal and diseased arteries Circulation 129 2014 2557 2566
2. Y. Zhang, W.J. Cliff, G.I. Schoefl, and G. Higgins Immunohistochemical study of intimal microvessels in coronary atherosclerosis Am. J. Pathol. 143 1993 164 172
3. E.R. O'Brien, M.R. Garvin, R. Dev, D.K. Stewart, T. Hinohara, J.B. Simpson, and S.M. Schwartz Angiogenesis in human coronary atherosclerotic plaques Am. J. Pathol. 145 1994 883 894
4. M. Kumamoto, Y. Nakashima, and K. Sueishi Intimal neovascularization in human coronary atherosclerosis: Its origin and pathophysiological significance Hum. Pathol. 26 1995 450 456
5. P.R. Moreno, K.R. Purushothaman, V. Fuster, D. Echeverri, H. Truszczynska, S.K. Sharma, J.J. Badimon, and W.N. O'Connor Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: Implications for plaque vulnerability Circulation 110 2004 2032 2038
6. R. Khurana, M. Simons, J.F. Martin, and I.C. Zachary Role of angiogenesis in cardiovascular disease: A critical appraisal Circulation 112 2005 1813 1824
7. K.S. Moulton Angiogenesis in atherosclerosis: gathering evidence beyond speculation Curr. Opin. Lipidol. 17 2006 548 555
8. M.M. Kockx, K.M. Cromheeke, M.W. Knaapen, J.M. Bosmans, G.R. De Meyer, A.G. Herman, and H. Bult Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 440 446
9. G.E. Davis, and D.R. Senger Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization Circ. Res. 97 2005 1093 1107
10. F.D. Kolodgie, H.K. Gold, A.P. Burke, D.R. Fowler, H.S. Kruth, D.K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, J. Narula, A.V. Finn, and R. Virmani Intraplaque hemorrhage and progression of coronary atheroma N. Engl. J. Med. 349 2003 2316 2325
11. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
12. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: An enigmatic signalling lipid Nat. Rev. Mol. Cell Biol. 4 2003 397 407
13. J.R. Stone, and T. Collins The role of hydrogen peroxide in endothelial proliferative responses Endothelium 9 2002 231 238
14. M. Ushio-Fukai Redox signaling in angiogenesis: Role of NADPH oxidase Cardiovasc. Res. 71 2006 226 235
15. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
16. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
17. V.N. Bochkov, M. Philippova, O. Oskolkova, A. Kadl, A. Furnkranz, E. Karabeg, T. Afonyushkin, F. Gruber, J. Breuss, A. Minchenko, D. Mechtcheriakova, P. Hohensinner, K. Rychli, J. Wojta, T. Resink, P. Erne, B.R. Binder, and N. Leitinger Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions Circ. Res. 99 2006 900 908
18. A. Dandapat, C. Hu, L. Sun, and J.L. Mehta Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway Arterioscler. Thromb. Vasc. Biol. 27 2007 2435 2442
19. R. Hutter, W.S. Speidl, C. Valdiviezo, B. Sauter, R. Corti, V. Fuster, and J.J. Badimon Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1alpha activation: A novel aspect of angiogenesis in atherosclerosis J. Cardiovasc. Transl. Res. 6 2013 558 569
20. C. Camare, M. Trayssac, B. Garmy-Susini, E. Mucher, R. Sabbadini, R. Salvayre, and A. Negre-Salvayre Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: Prevention by anti-S1P antibody Br. J. Pharmacol. 172 2015 106 118
21. T. Hla Signaling and biological actions of sphingosine 1-phosphate Pharmacol. Res. 47 2003 401 407
22. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell Biol. 9 2008 139 150
23. G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-phosphate: A regulator of arterial lesions Arterioscler. Thromb. Vasc. Biol. 29 2009 1439 1443
24. S.M. Pitson Regulation of sphingosine kinase and sphingolipid signaling Trends Biochem. Sci. 36 2011 97 107
25. C. Cinq-Frais, C. Coatrieux, M.H. Grazide, Y.A. Hannun, A. Negre-Salvayre, R. Salvayre, and N. Auge A signaling cascade mediated by ceramide, src and PDGFRbeta coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1 Biochim. Biophys. Acta 1831 2013 1344 1356
26. F.E. Rey, M.E. Cifuentes, A. Kiarash, M.T. Quinn, and P.J. Pagano Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice Circ. Res. 89 2001 408 414 2001
27. M. Sanson, C. Ingueneau, C. Vindis, J.C. Thiers, Y. Glock, H. Rousseau, Y. Sawa, Y. Bando, Z. Mallat, R. Salvayre, and A. Negre-Salvayre Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDL in vascular cells Cell Death Differ. 15 2008 1255 1265
28. M. Zhou, Z. Diwu, N. Panchuk-Voloshina, and R.P. Haugland A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases Anal. Biochem. 253 1997 162 168
29. R. Devillard, S. Galvani, J.C. Thiers, J.L. Guenet, Y. Hannun, J. Bielawski, A. Negre-Salvayre, R. Salvayre, and N. Auge Stress-induced sphingolipid signaling: Role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation PLoS One 5 2010 e9826
30. A. Passaniti, R.M. Taylor, R. Pili, Y. Guo, P.V. Long, J.A. Haney, R.R. Pauly, D.S. Grant, and G.R. Martin A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor Lab. Invest. 67 1992 519 528
31. R.B. Rema, K. Rajendran, and M. Ragunathan Angiogenic efficacy of Heparin on chick chorioallantoic membrane Vasc. Cell 4 2012 8
32. C.J. Clarke, B.X. Wu, and Y.A. Hannun The neutral sphingomyelinase family: Identifying biochemical connections Adv. Enzyme Regul. 51 2011 51 58
33. A.A. Shamseddine, M.V. Airola, and Y.A. Hannun Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes Adv. Biol. Regul. 57 2015 24 41
34. M. Yasuda, Y. Ohzeki, S. Shimizu, S. Naito, A. Ohtsuru, T. Yamamoto, and Y. Kuroiwa Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells Life Sci. 64 1999 249 258
35. P. Rocic, C. Kolz, R. Reed, B. Potter, and W.M. Chilian Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2729 H2736
36. 2. Role in cell survival following oxidant injury J. Biol. Chem. 271 1996 4138 4142
37. S. Filosto, W. Fry, A.A. Knowlton, and T. Goldkorn Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B) J. Biol. Chem. 285 2010 10213 10222
38. H. Adachi, and M. Tsujimoto Endothelial scavenger receptors Prog. Lipid Res. 45 2006 379 404
39. L. Cominacini, A.F. Pasini, U. Garbin, A. Davoli, M.L. Tosetti, M. Campagnola, A. Rigoni, A.M. Pastorino, V. Lo Cascio, and T. Sawamura Oxidized LDL binding to LOX-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species J. Biol. Chem. 275 2000 12633 12638
40. N. Auge, N. Andrieu, A. Negre-Salvayre, J.C. Thiers, T. Levade, and R. Salvayre The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation J. Biol. Chem. 271 1996 19251 19255
41. M. Harada-Shiba, M. Kinoshita, H. Kamido, and K. Shimokado Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms J. Biol. Chem. 273 1998 9681 9687
42. I. Escargueil-Blanc, N. Andrieu-Abadie, S. Caspar-Bauguil, R. Brossmer, T. Levade, A. Negre-Salvayre, and R. Salvayre Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells J. Biol. Chem. 273 1998 27389 27395
43. R.J. Veldman, N. Maestre, O.M. Aduib, J.A. Medin, R. Salvayre, and T. Levade A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: Potential implications in tumour necrosis factor signalling Biochem. J. 355 2001 859 868
44. S. Yu, S.L. Wong, C.W. Lau, Y. Huang, and C.M. Yu Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells Biochem. Biophys. Res. Commun. 407 2011 44 48
45. M. Levy, S.S. Castillo, and T. Goldkorn nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis Biochem. Biophys. Res. Commun. 344 2006 900 905
46. C. Stielow, R.A. Catar, G. Muller, K. Wingler, P. Scheurer, H.H. Schmidt, and H. Morawietz Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells Biochem. Biophys. Res. Commun. 344 2006 200 205
47. G. Rajashekhar, M. Kamocka, A. Marin, M.A. Suckow, W.R. Wolter, S. Badve, A.R. Sanjeevaiah, K. Pumiglia, E. Rosen, and M. Clauss Pro-inflammatory angiogenesis is mediated by p38 MAP kinase J. Cell. Physiol. 226 2011 800 808
48. C. De Palma, E. Meacci, C. Perrotta, P. Bruni, and E. Clementi Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: A novel pathway relevant to the pathophysiology of endothelium Arterioscler. Thromb. Vasc. Biol. 26 2006 99 105
49. S.M. Colles, J.M. Maxson, S.G. Carlson, and G.M. Chisolm Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols Trends Cardiovasc. Med. 11 2001 131 138
50. R. Salvayre, N. Auge, H. Benoist, and A. Negre-Salvayre Oxidized low-density lipoprotein-induced apoptosis Biochim. Biophys. Acta 1585 2002 213 221
51. C. Napoli Oxidation of LDL, atherogenesis, and apoptosis Ann. N. Y. Acad. Sci. 1010 2003 698 709
52. V. Lubrano, and S. Balzan LOX-1 and ROS, inseparable factors in the process of endothelial damage Free Radic. Res. 48 2014 841 848
53. D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.H. Seguelas, N. Leducq, I. Seif, A. Parini, and O. Cuvillier Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis Circ. Res. 100 2007 41 49
54. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478
55. I. Levitan, S. Volkov, and P.V. Subbaiah Oxidized LDL: Diversity, patterns of recognition, and pathophysiology Antioxid. Redox Signal. 13 2010 39 75
56. E. Falk, M. Nakano, J.F. Bentzon, A.V. Finn, and R. Virmani Update on acute coronary syndromes: The pathologists′ view Eur. Heart J. 34 2013 719 728
57. D.H. Deutschman, J.S. Carstens, R.L. Klepper, W.S. Smith, M.T. Page, T.R. Young, L.A. Gleason, N. Nakajima, and R.A. Sabbadini Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate Am. Heart J. 146 2003 62 68